{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:48Z","timestamp":1790015508319,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.vaccine.2014.04.059","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T15:00:12Z","timestamp":1398783612000},"page":"3480-3487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada"],"prefix":"10.1016","volume":"32","author":[{"given":"Isabelle","family":"Rouleau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta M.","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Philippe","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Lemire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.04.059_bib0005","series-title":"Bilan de la Direction g\u00e9n\u00e9rale de la sant\u00e9 publlique de la vaccination contre la grippe pand\u00e9mique A(H1N1) du 22 octobre au 18 d\u00e9cembre 2009","author":"Auger","year":"2011"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0010","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.1016\/j.vaccine.2013.10.033","article-title":"Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A\/H1N1 (H1N1 pdm09) vaccine","volume":"31","author":"Rouleau","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0015","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaci.2012.07.019","article-title":"Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE","volume":"130","author":"Rouleau","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0020","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2012.11.095","article-title":"Investigation of an outbreak of hypersensitivity-type reactions during the 2004 national measles-mumps-rubella vaccination campaign in Brazil","volume":"31","author":"Freitas","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7883\/yoken.64.183","article-title":"The adverse events of influenza A (H1N1) vaccination and its risk factors in healthcare personnel in 18 military healthcare units in Korea","volume":"64","author":"Hwang","year":"2011","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0030","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/ACI.0b013e328355b7e4","article-title":"2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis","volume":"12","author":"Simons","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/WOX.0b013e318211496c","article-title":"World allergy organization guidelines for the assessment and management of anaphylaxis","volume":"4","author":"Simons","year":"2011","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0040","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354543","article-title":"World allergy organization anaphylaxis guidelines: 2013 update of the evidence base","volume":"162","author":"Simons","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0045","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaci.2013.01.011","article-title":"Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis","volume":"131","author":"Lee","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0050","series-title":"Loi sur la sant\u00e9 publique (L.R.Q., chapitre S-2.2, mis \u00e0 jour le 1er mars 2005)","author":"Gouvernement du Qu\u00e9bec","year":"2001"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0060","series-title":"Canadian Immunization Guide","author":"National Advisory Committee on Immunization","year":"2006"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0075","series-title":"American Academy of Neurology 2011 Annual Meeting","article-title":"Anesthesia\/paresthesia following immunization with an adjuvanted monovalent pandemic influenza vaccine: results of an epidemiological investigation in Quebec, Canada","author":"Lacroix","year":"2011"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0080","series-title":"Guidelines for ATC classification and DDD assignment 2013","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2012"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0085","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u00fcggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0090","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/S0264-410X(03)00094-X","article-title":"The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination","volume":"21","author":"De Serres","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0095","series-title":"Middleton's allergy: principles & practice","article-title":"Adverse reactions to vaccines for infectious disease","author":"Kelso","year":"2009"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0100","series-title":"MWSUG 2009, Proceedings, Midwest SAS Users Group, Inc., Paper D10-2009","article-title":"Ranking predictors in logistic regression","author":"Thompson","year":"2009"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/milmed\/161.1.29","article-title":"Side effects from influenza vaccination: differences between returned and random surveys","volume":"161","author":"Robb","year":"1996","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0110","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0115","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1001\/archinternmed.2008.513","article-title":"Half- vs full-dose trivalent inactivated influenza vaccine (2004\u20132005): age, dose, and sex effects on immune responses","volume":"168","author":"Engler","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbi.2005.07.001","article-title":"Acute stress exposure prior to influenza vaccination enhances antibody response in women","volume":"20","author":"Edwards","year":"2006","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bbi.2006.04.158","article-title":"Eccentric exercise as an adjuvant to influenza vaccination in humans","volume":"21","author":"Edwards","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0130","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1016\/j.vaccine.2006.04.032","article-title":"Immune response to influenza vaccination in community-dwelling Chinese elderly persons","volume":"24","author":"Hui","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0135","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1016\/j.vaccine.2007.08.042","article-title":"Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects","volume":"25","author":"Couch","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0140","doi-asserted-by":"crossref","first-page":"12182","DOI":"10.1128\/JVI.75.24.12182-12187.2001","article-title":"Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals","volume":"75","author":"Goronzy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0145","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.vaccine.2005.11.057","article-title":"Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults","volume":"24","author":"Cook","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0150","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/all.12193","article-title":"About the role and underlying mechanisms of cofactors in anaphylaxis","volume":"68","author":"Wolbing","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0155","doi-asserted-by":"crossref","first-page":"E146","DOI":"10.1503\/cmaj.091678","article-title":"Rash associated with pandemic (H1N1) influenza","volume":"182","author":"Rosenberg","year":"2010","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1750-2659.2011.00197.x","article-title":"Rash an uncommon but existing feature of H1N1 influenza among children","volume":"5","author":"Fretzayas","year":"2011","journal-title":"Influenza Other Respir Viruses"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.04.059_bib0165","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1017\/S0007114507838049","article-title":"Moderate alcohol consumption and the immune system: a review","volume":"98","author":"Romeo","year":"2007","journal-title":"Br J Nutr"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0170","first-page":"257","article-title":"Influence of alcohol and gender on immune response","volume":"26","author":"Kovacs","year":"2002","journal-title":"Alcohol Res Health: J Natl Inst Alcohol Abuse Alcohol"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/15245004.2010.546943","article-title":"Evaluating a county-sponsored social marketing campaign to increase mothers\u2019 initiation of HPV vaccine for their pre-teen daughters in a primarily rural area","volume":"17","author":"Cates","year":"2011","journal-title":"Soc Mar Q"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0180","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.addbeh.2009.11.001","article-title":"Social desirability biases in self-reported alcohol consumption and harms","volume":"35","author":"Davis","year":"2010","journal-title":"Addict Behav"},{"key":"10.1016\/j.vaccine.2014.04.059_bib0185","series-title":"Les Qu\u00e9b\u00e9cois et l\u2019alcool 2012","first-page":"70","author":"\u00c9duc Alcool","year":"2012"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14005970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T07:24:19Z","timestamp":1716708259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14005970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":34,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0264410X14005970"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.04.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}